Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis

Clinical trial NCT04588077 · RECRUITING

Trial details

NCT number: NCT04588077
Sponsor: Mercy Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis B Cirrhosis, Liver Chronic Liver Disease

Start date: 2020-09-14
Primary completion: 2028-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.